Today: 6 April 2026
Subscribe
Browse Category

Stock Market 15 October 2025

Palantir (PLTR) Stock Rockets on AI Hype & Major Contracts – Bubble or Boom?

Palantir (PLTR) Stock Rockets on AI Hype & Major Contracts – Bubble or Boom?

Palantir shares traded near $180 on Oct. 15, 2025, up about 360% year-on-year after landing a $10 billion U.S. Army contract and a £750 million UK defense deal. Q2 revenue hit $1 billion for the first time, up 48% from a year earlier. A leaked Army memo on security flaws briefly sent shares down 7.5%, but the stock rebounded. Analyst targets range widely, with a median of $150–$160.
15 October 2025
··
Bitfarms Stock Skyrockets 148% YTD on Bitcoin Boom and AI Pivot – Latest News & Outlook

Bitfarms Stock Skyrockets 148% YTD on Bitcoin Boom and AI Pivot – Latest News & Outlook

Bitfarms shares surged over 600% in six months, closing at $5.89 on Oct. 14 after eight straight daily gains and record trading volume. The rally follows Bitcoin’s run to $125,000, a CFO change, a 10% buyback, and a shift into AI data centers. Bitfarms secured $300 million financing for a Pennsylvania campus. Analysts remain cautious, with price targets below current levels and the company still unprofitable.
15 October 2025
···
BigBear.ai Stock Soars Amid AI Boom – What’s Behind BBAI’s Wild 2025 Ride?

BigBear.ai Stock Soars on New Defense Deals – Can BBAI’s Rally Continue?

BigBear.ai shares jumped 22% on Oct. 13 after announcing a new defense partnership, pushing the stock near $9 and more than doubling its value in 2025. Despite the rally, Q2 revenue fell 18% to $32.5 million and net loss widened to $228.6 million. Analysts remain cautious, with most rating the stock “Hold” and a $6 average price target. Trading volume spiked to 172 million shares on Oct. 14.
15 October 2025
·····
Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides

Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides

A federal judge on Oct. 14 upheld the U.S. government’s downgrade of Humana’s 2025 Medicare Advantage star rating from 4.5 to 3.5 stars, dismissing Humana’s lawsuit. The ruling leaves about 45% of Humana’s Medicare Advantage members in lower-rated plans and could cost the company an estimated $1 billion in lost federal bonus payments next year. Humana shares fell 3–4% on the news. The company said it may appeal.
15 October 2025
·
Uber Stock Poised to Soar? Guggenheim’s $140 Price Target Explained

Uber Stock Poised to Soar? Guggenheim’s $140 Price Target Explained

Guggenheim initiated Uber coverage with a Buy rating and $140 price target, citing its network, technology, and brand. The firm projects autonomous vehicles will handle about 20% of U.S. rideshare trips by 2035. Uber shares closed at $94 on Oct. 14, with analysts’ consensus 12-month target near $105–107. Recent catalysts include strong Q3 results and the acquisition of AI startup Segments.ai.
15 October 2025
··
Sable Offshore Corp (SOC) Stock Plummets on Legal Setback – What’s Next for the Embattled Oil Driller?

Sable Offshore Corp (SOC) Stock Plummets on Legal Setback – What’s Next for the Embattled Oil Driller?

Sable Offshore Corp. shares fell about 25% on October 15 after a California judge tentatively ruled against the company in a key pipeline dispute. The stock traded near its 52-week low at $13.70 midday. Sable faces lawsuits and criminal charges from state officials over alleged environmental violations and has threatened to bypass California with a tanker-based oil export plan. Analysts remain divided on the company’s prospects.
15 October 2025
··
Credo Technology (CRDO) Stock Rebounds on AI Partnership as Analysts Eye Long-Term Growth

Credo Technology (CRDO) Stock Rebounds on AI Partnership as Analysts Eye Long-Term Growth

Credo Technology Group shares plunged 13% Tuesday to $129.75 after surging to nearly $150 earlier in the week, then rebounded 6% in pre-market trading Wednesday. The company unveiled new “ZeroFlap” optical transceivers and joined Arm’s Total Design ecosystem to co-develop custom AI silicon. Credo also filed for a $750 million stock offering and acquired Hyperlume for about $40–50 million. Revenue jumped 273% last quarter to $223 million.
15 October 2025
···
PNC Financial Stock Oversold – Q3 Earnings Beat & Analyst Upgrades Fuel Rebound Hopes

PNC Financial Stock Oversold – Q3 Earnings Beat & Analyst Upgrades Fuel Rebound Hopes

PNC Financial closed at $189.73 on October 15, 2025, nearly unchanged from a year earlier. The bank beat Q3 earnings estimates with EPS of $4.35 and revenue of $5.92 billion but issued cautious Q4 net interest income guidance. Shares briefly entered oversold territory last week amid market volatility. Analysts, including Piper Sandler and Wells Fargo, have raised price targets, citing solid fundamentals.
15 October 2025
··
Blaize Holdings (BZAI) Soars on AI Chip Deals and Partnerships – What’s Next for This Edge AI Stock?

Blaize Holdings (BZAI) Soars on AI Chip Deals and Partnerships – What’s Next for This Edge AI Stock?

Blaize Holdings shares jumped 45% in two weeks to $5.90 on October 15, 2025, after landing $176 million in AI contracts across Asia. The company’s sales pipeline now totals $725 million through 2027, and 2025 revenue guidance is $35–38 million, up from $3.8 million last year. Despite analyst debate, the consensus 12-month price target is $7.50. Shares remain well below their $19.25 post-IPO high.
15 October 2025
·
FuelCell Energy Stock Skyrockets on AI Data Center Boom – 97% Revenue Surge Ignites Green Energy Hype

FuelCell Energy Stock Skyrockets on AI Data Center Boom – 97% Revenue Surge Ignites Green Energy Hype

FuelCell Energy shares have surged 150% in the past month, recently trading near $12 after Bloom Energy announced a $5 billion AI data-center deal. Fiscal Q3 revenue nearly doubled to $46.7 million, but net loss widened to $92.5 million on restructuring charges. The company cut 17% of its workforce and is targeting AI-driven power demand. Analysts remain cautious, with a consensus price target below current levels.
15 October 2025
·····
Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough

Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough

Evaxion shares jumped 25% on Oct 14, closing at $7.84, after Merck exercised its option on the EVX-B3 vaccine, paying $7.5 million upfront with up to $592 million in milestones. Evaxion will present two-year Phase 2 data for its AI-designed melanoma vaccine at ESMO on Oct 17. The company also announced an upgrade to its AI-Immunology platform and maintains a “Strong Buy” rating from analysts.
15 October 2025
···
Indie Semiconductor (INDI) Stock Rockets to New Highs on Q2 Beat and AI Tech Wins

Indie Semiconductor (INDI) Stock Rockets to New Highs on Q2 Beat and AI Tech Wins

Indie Semiconductor shares surged 19% to a 52-week high of $5.58 on Oct. 14, closing at $5.56 after heavy trading. Q2 revenue reached $51.6M, beating consensus, with non-GAAP EPS of –$0.08 in line. Indie plans to acquire Vienna’s emotion3D for $20M plus up to $10M in earnouts, with closing expected in Q4. The company also unveiled a new GaN visible-laser for quantum computing and automotive LiDAR.
15 October 2025
···
Stem, Inc. (NASDAQ: STEM) Stock Skyrockets on European Expansion and Analyst Upgrades

Stem, Inc. (NASDAQ: STEM) Stock Skyrockets on European Expansion and Analyst Upgrades

Stem shares jumped 16% to $27.52 on Oct. 14, 2025, after announcing a new 400 m² Berlin center to support European solar-plus-storage projects. The stock is up 173% over 90 days. Q2 revenue beat forecasts at $38.4 million, but the company posted a ($3.73) per-share loss. Analysts remain divided, with price targets ranging from $12 to $21 and most rating the stock “Hold.”
15 October 2025
··
SA Executive Pay Explosion: CFOs’ Salaries Spike 19% While CEOs Rise 8%

SA Executive Pay Explosion: CFOs’ Salaries Spike 19% While CEOs Rise 8%

South African CFOs saw median pay jump 19% to R12.6 million in 2025, outpacing CEOs, whose pay rose 8% to R21.3 million, according to PwC. The increases reflect bigger base salaries and higher bonuses. Boards are tying more pay to performance, mirroring UK and US trends. Nearly 92% of JSE Top-200 shareholders approved executive pay policies, but new transparency rules are pending.
15 October 2025
Morgan Stanley Q3 Earnings Skyrocket – Are Big Banks Making a Comeback?

Morgan Stanley Q3 Earnings Skyrocket – Are Big Banks Making a Comeback?

Morgan Stanley reported Q3 net income of $4.6 billion, up from $3.2 billion a year earlier, with record revenue of $18.2 billion. Investment banking fees jumped 44% to $2.11 billion, and wealth management revenue hit $8.2 billion with a 30.3% pre-tax margin. Shares closed at $155 on Oct. 14 and rose 1.2% pre-market Oct. 15. Analysts cited strong deal activity and expectations of Fed rate cuts.
15 October 2025
··
Quantum-Powered Pop! SEALSQ Corp (LAES) Stock Rockets on Latest Breakthroughs and Deals

Quantum Security Frenzy: SEALSQ (LAES) Stock Skyrockets on Deals & Chip Breakthroughs

SEALSQ Corp shares jumped nearly fivefold since summer, closing at $7.65 on Oct. 14 after a week of heavy trading and major post-quantum security deals. The company reported 41% year-over-year revenue growth for the first nine months and raised $69 million to fund expansion. New quantum-secure chips and a satellite launch are planned for 2025. Most analysts remain cautious, citing volatility and lack of profitability.
15 October 2025
···
ASX:COOT TRIPLES AS TRADE WAR TALK IGNITES AGRI STOCK RALLY

ASX:COOT TRIPLES AS TRADE WAR TALK IGNITES AGRI STOCK RALLY

Australian Oilseeds (COOT) stock soared over 300% from $0.97 to about $4.00 in early trading Oct. 15, following U.S. President Trump’s threat to cut cooking oil imports from China. Trading volume spiked from 170,000 to 85 million shares. The rally spread to peers Origin Agritech and Arcadia Biosciences, which also posted large after-hours gains. COOT recently regained Nasdaq compliance and expanded its China market presence.
15 October 2025
···
1 … 1,313 1,314 1,315 1,316 1,317 … 1,371

Stock Market Today

  • GitLab (GTLB) Stock Seen Undervalued by 58.9% Despite Recent Volatility
    April 5, 2026, 7:54 PM EDT. GitLab's shares have swung notably, rising 10.9% last week but down 37.6% year-to-date, sparking interest among investors. A discounted cash flow (DCF) analysis, which estimates intrinsic value based on projected future cash flow, values GitLab at about $54.97 per share. This suggests the current price around $22.57 trades at a 58.9% discount, indicating the stock is undervalued. Despite a mixed short-term performance, GitLab's longer-term forecast shows projected free cash flow growth, underscoring potential opportunity. Market watchers are weighing if recent share price moves fairly reflect the company's prospects or if the stock offers a buying chance amid volatility.
Go toTop